Researchers have tested a new treatment in humans for the first time, and the initial results are promising!
This treatment targets not just symptoms, but a key disease process in the brain—a promising step forward.

It involves an innovative form of therapy that helps inhibit the production of a harmful protein. It is important to emphasize that this is an initial study in humans; however, it demonstrates the intense global effort to find new ways to slow down—and ultimately halt—Parkinson’s disease.
–
.
.
.
.